Transactions
Sep. 12, 2000
Pillsbury Madison: GENETICS COMPANY DELTAGEN GOES PUBLIC
By Victoria Newman and John Ryan. Menlo Park's Deltagen Inc. has gone public in an offering valued at $105 million. The company's products aid in the production and analysis of genetic information. Drug companies subscribe to its database of mammalian gene functions and use its selection program to identify drug-discovery targets. Chief customers include Pfizer and Roche Biosciences.
Menlo Park's Deltagen Inc. has gone public in an offering valued at $105 million.
The company's products aid in the production and analysis of genetic information. Drug companies subscribe to its database of mammalian gene functions and use its selectio...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In